Breaks Categories: Stock Spotlights

FridayJun 06, 2025 3:13 pm

NetworkNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positioning at the Center of Critical Materials, Innovation

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is strategically positioning itself for growth amid strong palladium market dynamics, driven by constrained supply and continued industrial demand. With palladium essential in automotive, electronics, and emerging clean energy applications, the company is advancing the Waterberg Project in South Africa—one of the largest undeveloped primary palladium and platinum projects globally. In partnership with Anglo American Platinum Limited, PLG is also investing in future-focused innovation through Lion Battery Technologies, which explores the use of platinum and palladium in next-generation lithium battery technologies. Among the few companies combining traditional mining development with tech-driven diversification, Platinum…

Continue Reading

FridayJun 06, 2025 1:51 pm

NetworkNewsBreaks – Why Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’

Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. INBS was featured in a recent article that reads, “By utilizing fingerprint sweat analysis, the company offers a cost-effective, hygienic solution to detect recent drug use — targeting substances commonly found in workplace settings… The company’s vision is to redefine drug screening by removing the pain points of traditional testing methods, including biohazardous waste, privacy concerns, and long result turnaround times. With results in under 10 minutes and no need for gender-specific collectors or laboratory facilities, the system empowers…

Continue Reading

WednesdayJun 04, 2025 3:41 pm

NetworkNewsBreaks – Adageis Empowers Providers with Actionable Insights for Value-Based Care Success

Adageis, a growing healthcare technology company, offers a unique streamlined and AI-powered software solution designed to make the shift toward value-based care simpler for healthcare practices. “At the core of the company’s offering is the ProActive Care Platform, a patented, AI-centric engine that enables providers, health systems, ACOs, and CINs to identify and act on high-value opportunities within their existing operations,” reads a recent article. “What sets Adageis apart is ease of use, giving practices clear, actionable insights on where value lies, and how to pursue it while maintaining or improving quality of care.” To view the full article, visit…

Continue Reading

WednesdayJun 04, 2025 2:26 pm

NetworkNewsBreaks – AI-Driven Lending: FAVO Capital Inc. (FAVO) Sets New Standard in Funding Solutions for SMBs

FAVO Capital (OTC: FAVO) is a rapidly growing private credit company dedicated to providing fast, efficient, and personalized funding solutions for small and medium-sized businesses (“SMBs”). “FAVO Capital has more than $138 million in total funding supporting more than 10,000 businesses. The company leverages artificial intelligence (‘AI’)-powered analytics to provide faster, smarter funding decisions,” reads a recent article. “Publicly listed and regulated, FAVO Capital is committed to transparency and investor confidence. The company has expanded its market reach, currently operating in 45 states and the Dominican Republic. FAVO’s fast, flexible financing can result in funding delivered within hours, as it executes…

Continue Reading

FridayMay 30, 2025 3:41 pm

NetworkNewsBreaks – Innovation in Motion: Massimo Group (NASDAQ: MAMO) Launches Fully Digital Retail Platform

Massimo Group (NASDAQ: MAMO) is entering a new growth phase with the launch of a comprehensive digital retail platform. This move is designed to simplify the purchasing process for its UTVs, ATVs, and mini-bikes, while expanding the company’s national sales footprint. “The platform enables customers to complete transactions online, including financing, titling, and checkout, providing a fully digital experience,” reads a recent article discussing the launch. “Massimo expects this shift to unlock greater scalability, reduce sales friction, and drive a significant increase in annual revenue.” To view the full article, visit https://nnw.fm/IQqdO About Massimo Group Massimo Group is a manufacturer and distributor…

Continue Reading

FridayMay 30, 2025 3:02 pm

NetworkNewsBreaks – Adageis’ AI-Powered Insights Aim to Improve Outcomes, Revenue Forecasting

Adageis, a forward-thinking healthcare technology company, has a comprehensive suite of AI-powered solutions aimed at providers shifting from fee-for-service to value-based care. “At the core of the company’s offering is its ProActive Care Platform, which combines predictive analytics with real-time data integration to improve both clinical and financial outcomes,” reads a recent article. “The platform’s Patented Risk Engine (‘PRE’) enables users to forecast revenue based on quality performance metrics and patient care patterns. For providers managing contracts that tie compensation to outcomes, these insights are increasingly important.” To view the full article, visit https://nnw.fm/Adageis About Adageis Adageis is a healthcare…

Continue Reading

FridayMay 23, 2025 3:45 pm

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) Unveils New Exploration Target, Boosting Montauban Project Potential

ESGold (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D), a fully permitted, pre-production resource company on a clear path to near-term gold and silver production, recently reported the identification of a significant geophysical anomaly in the southwest portion of its Montauban Project in Quebec. “According to a company press release, internal analysis of historical VTEM (Versatile Time Domain Electromagnetic) survey data and drill records has highlighted this area as a high-priority exploration target,” reads a recent article. “The zone, which has not yet been tested by drilling, displays a strong combination of electromagnetic conductivity and magnetic response, a dual signal often associated…

Continue Reading

FridayMay 23, 2025 2:45 pm

NetworkNewsBreaks – Why ONAR Holding Corp. (ONAR) Is ‘One to Watch’

ONAR (OTCQB: ONAR) is a leading marketing technology company and marketing agency network focused on delivering integrated, AI-driven solutions to accelerate revenue growth for its clients. “Through an agile agency network specializing in performance marketing, full-service healthcare marketing, experiential marketing, and technology incubation, ONAR provides best-in-class services to a growing roster of clients worldwide,” reads a recent article discussing the company. “Built on a foundation of innovation and operational excellence, ONAR’s vision is to redefine marketing services by leading with technological advancement. ONAR’s strategic growth model focuses on growing and acquiring proven agencies under one umbrella to deliver superior service offerings…

Continue Reading

ThursdayMay 22, 2025 3:55 pm

NetworkNewsBreaks – Soligenix Inc.’s (NASDAQ: SNGX) HyBryte(TM) Delivers Strong Results in Rare Cancer Trial

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is leading the way with innovative therapies for rare and difficult-to-treat diseases, particularly early-stage cutaneous T-cell lymphoma (“CTCL”), a rare form of cancer that affects the skin. “Soligenix’s proprietary treatment, HyBryte(TM), is currently in clinical trials, and the latest results have shown promising efficacy in treating CTCL,” reads a recent article. “‘Following 18 weeks of treatment, 75% of patients achieved ‘Treatment Success,’ reinforcing HyBryte(TM) as a potentially safe and fast-acting therapy for this chronic and underserved cancer,’ the company reported. The study results suggest that the treatment may be highly effective in reducing…

Continue Reading

ThursdayMay 22, 2025 2:55 pm

NetworkNewsBreaks – Calidi Biotherapeutics Inc.’s (NYSE American: CLDI) RTNova Shows Promise in Targeted Tumor Therapy

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its RTNova platform, a breakthrough in the delivery of transient gene therapy payloads to targeted tumors. The innovative platform not only targets cancer cells effectively but also minimizes harm to surrounding healthy tissues, potentially improving treatment outcomes and reducing side effects. As global cancer rates continue to rise, Calidi’s RTNova platform and tumor-specific virotherapy hold the promise of offering new hope to cancer patients, addressing the limitations of existing treatments, and potentially improving survival rates across multiple cancer types. The company’s ongoing research and deep commitment to scientific excellence position…

Continue Reading